Remove Myocardial Infarction Remove Research Remove Risk Factors
article thumbnail

A cost-sensitive deep neural network-based prediction model for the mortality in acute myocardial infarction patients with hypertension on imbalanced data

Frontiers in Cardiovascular Medicine

Background and objectives Hypertension is one of the most serious risk factors and the leading cause of mortality in patients with cardiovascular diseases (CVDs). Methods The synopsis of our research is as follows. It is necessary to accurately predict the mortality of patients suffering from CVDs with hypertension.

article thumbnail

Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks

DAIC

The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.

article thumbnail

Prognostic potential of inflammatory markers in chronic kidney disease patients combined with acute myocardial infarction

Frontiers in Cardiovascular Medicine

BackgroundInflammation significantly impacts chronic kidney disease (CKD) and acute myocardial infarction (AMI). Using univariate and multivariate logistic regression, we identified inflammation-related risk factors for MACCE.

article thumbnail

Short- and long-term mortality in patients with type 2 diabetes after myocardial infarction– a nationwide registry study

Cardiovascular Diabetology

Type 2 diabetes has traditionally been a risk factor for worse prognosis after myocardial infarction (MI), but major advances have been made in its treatment, and the use of secondary preventive measures has i.

article thumbnail

Correlation between admission blood glucose, fibrinogen, and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction

Frontiers in Cardiovascular Medicine

However, whether immediate blood glucose and FIB levels affect coronary blood flow during primary percutaneous coronary intervention (PCI) remains unclear.ObjectiveTo explore the correlation between admission blood glucose (ABG), fibrinogen (FIB) and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction (STEMI).MethodsA

article thumbnail

Abstract 4148106: Hemophilia and Cardiovascular disease in the United States: Prevalence, Risk factors, and outcomes.

Circulation

Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular risk factors in patients with hemophilia compared to the general population.

article thumbnail

BIDMC-led Trial Leads to FDA approval of Coronary Drug-coated Balloons

DAIC

In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. Smith Center for Outcomes Research in Cardiology and section chief of Interventional Cardiology at BIDMC. Yeh , MD, MSc, MBA, director of the Richard A. and Susan F. percent). “The

Stent 116